lumagem case study - rsna2014.rsna.orgrsna2014.rsna.org/files/827/case study.pdf · case history:...

Post on 05-Nov-2019

3 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

High Risk Screening MBI, 22% Lifetime Risk by Claus Model

Case History:

• 62 y/o with recent negative screening mammography referred for management of high risk status

• Abnormal MBI scan with focal uptake posterior LIQ left breast

• Diagnostic mammography and US demonstrated no significant findings , just a subtle 1.2 cm mass at 7:00 approximately 4 cm from the nipple by US

• 9 gauge vacuum-assisted needle USCN bx results: ILC & LCIS

• Breast MRI showed 1.4 cm index lesion and adjacent 6mm ILC satellite and extensive LCIS in posterior LIQ left breast

• Final surgical pathology results: 1.2 cm ILC with adjacent 6mm ILC satellite and extensive LCIS in posterior LIQ left breast pathology staging: pT1c(m), pN0(sn), cM0, Stage 1A

LumaGEM Case Study ®

Molecular Breast Imaging (MBI) Diagnostic Mammography

Ultrasound MRI

Gamma Medica, Inc.

12 Manor Parkway, Unit 3, Salem, NH 03079 • Toll Free: +1 888.720.3152 • Tel: +1 603.952.4441 • Fax: +1 603.870.8045

Email: info@gammamedica.com • www.gammamedica.com

Images Courtesy of Houston Methodist Sugar Land Hospital, Breast Imaging Center, Houston, TX

LumaGEM is a registered trademark of Gamma Medica, Inc. © 2013 Gamma Medica, Inc. All rights reserved.

top related